TY - CHAP
T1 - Manipulating the p53 gene in the mouse
T2 - Organismal functions of a prototype tumor suppressor
AU - Donehower, Lawrence A.
AU - Bocangel, Dora
AU - Dumble, Melissa
AU - Lozano, Guillermina
N1 - Publisher Copyright:
© 2007 Springer. All Rights Reserved.
PY - 2005
Y1 - 2005
N2 - The early discoveries elucidating p53 function were based on cell culture experiments. Most of our fundamental knowledge of the role of p53 in cell signaling, stress response, cell cycle control, and apoptosis are a result of these in vitro studies (Giaccia and Kastan, 1998; Ko and Prives, 1996; Levine, 1997; Vogelstein et al., 2000). However, a greater depth of understanding was facilitated by the advent first of transgenic mouse methodologies and then by embryonic stem (ES) cell-based genetic manipulations. The sequencing of the mouse genome (www.ensembl.org and www.myscience.appliedbiosystems.com) has greatly simplified and accelerated the generation of null alleles. Methods have been developed to generate single nucleotide substitutions in the germline of mice, and importantly, to generate somatic mutations in genes to study somatic inactivation as occurs in most human cancers. The availability of whole genome analysis at the RNA expression level (arrays) and at the genomic level (array CGH) provides another level of analysis that is sure to provide insights into the molecular changes that lead to the initiation, progression, and maintenance of the tumor phenotype.
AB - The early discoveries elucidating p53 function were based on cell culture experiments. Most of our fundamental knowledge of the role of p53 in cell signaling, stress response, cell cycle control, and apoptosis are a result of these in vitro studies (Giaccia and Kastan, 1998; Ko and Prives, 1996; Levine, 1997; Vogelstein et al., 2000). However, a greater depth of understanding was facilitated by the advent first of transgenic mouse methodologies and then by embryonic stem (ES) cell-based genetic manipulations. The sequencing of the mouse genome (www.ensembl.org and www.myscience.appliedbiosystems.com) has greatly simplified and accelerated the generation of null alleles. Methods have been developed to generate single nucleotide substitutions in the germline of mice, and importantly, to generate somatic mutations in genes to study somatic inactivation as occurs in most human cancers. The availability of whole genome analysis at the RNA expression level (arrays) and at the genomic level (array CGH) provides another level of analysis that is sure to provide insights into the molecular changes that lead to the initiation, progression, and maintenance of the tumor phenotype.
UR - http://www.scopus.com/inward/record.url?scp=84919639877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84919639877&partnerID=8YFLogxK
U2 - 10.1007/978-1-4020-2922-6_8
DO - 10.1007/978-1-4020-2922-6_8
M3 - Chapter
AN - SCOPUS:84919639877
SN - 9781402029202
SP - 183
EP - 207
BT - 25 Years of p53 Research
PB - Springer Netherlands
ER -